These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 7971715)
21. In vitro and in vivo evaluation of thyrotrophin releasing hormone release from copoly(dl-lactic/glycolic acid) microspheres. Heya T; Okada H; Ogawa Y; Toguchi H J Pharm Sci; 1994 May; 83(5):636-40. PubMed ID: 8071811 [TBL] [Abstract][Full Text] [Related]
22. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres. Blanco-Príeto MJ; Campanero MA; Besseghir K; Heimgatner F; Gander B J Control Release; 2004 May; 96(3):437-48. PubMed ID: 15120900 [TBL] [Abstract][Full Text] [Related]
23. Formulation and in vitro-in vivo evaluation of black raspberry extract-loaded PLGA/PLA injectable millicylindrical implants for sustained delivery of chemopreventive anthocyanins. Desai KG; Olsen KF; Mallery SR; Stoner GD; Schwendeman SP Pharm Res; 2010 Apr; 27(4):628-43. PubMed ID: 20148292 [TBL] [Abstract][Full Text] [Related]
24. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist. Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531 [TBL] [Abstract][Full Text] [Related]
25. Mechanistic evaluation of the initial burst release of leuprolide from spray-dried PLGA microspheres. Schutzman R; Shi NQ; Olsen KF; Ackermann R; Tang J; Liu YY; Hong JKY; Wang Y; Qin B; Schwendeman A; Schwendeman SP J Control Release; 2023 Sep; 361():297-313. PubMed ID: 37343723 [TBL] [Abstract][Full Text] [Related]
26. Preparation of poly(D,L-lactide) and copoly(lactide-glycolide) microspheres of uniform size. Shiga K; Muramatsu N; Kondo T J Pharm Pharmacol; 1996 Sep; 48(9):891-5. PubMed ID: 8910847 [TBL] [Abstract][Full Text] [Related]
27. Determinants of release rate of tetanus vaccine from polyester microspheres. Alonso MJ; Cohen S; Park TG; Gupta RK; Siber GR; Langer R Pharm Res; 1993 Jul; 10(7):945-53. PubMed ID: 8378256 [TBL] [Abstract][Full Text] [Related]
28. An investigation into the effects of residual water on the glass transition temperature of polylactide microspheres using modulated temperature DSC. Passerini N; Craig DQ J Control Release; 2001 May; 73(1):111-5. PubMed ID: 11337064 [TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid). Gao P; Ding P; Xu H; Yuan Z; Chen D; Wei J; Chen D Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):89-93. PubMed ID: 16394556 [TBL] [Abstract][Full Text] [Related]
37. Preparation of glucagon-like peptide-1 loaded PLGA microspheres: characterizations, release studies and bioactivities in vitro/in vivo. Yin D; Lu Y; Zhang H; Zhang G; Zou H; Sun D; Zhong Y Chem Pharm Bull (Tokyo); 2008 Feb; 56(2):156-61. PubMed ID: 18239299 [TBL] [Abstract][Full Text] [Related]
38. Biodegradable polymer-silica xerogel composite microspheres for controlled release of gentamicin. Xue JM; Tan CH; Lukito D J Biomed Mater Res B Appl Biomater; 2006 Aug; 78(2):417-22. PubMed ID: 16470829 [TBL] [Abstract][Full Text] [Related]
39. The nature of peptide interactions with acid end-group PLGAs and facile aqueous-based microencapsulation of therapeutic peptides. Sophocleous AM; Desai KG; Mazzara JM; Tong L; Cheng JX; Olsen KF; Schwendeman SP J Control Release; 2013 Dec; 172(3):662-70. PubMed ID: 24021356 [TBL] [Abstract][Full Text] [Related]
40. In vivo evaluation of solid lipid microparticles and hybrid polymer-lipid microparticles for sustained delivery of leuprolide. Wu C; Luo X; Baldursdottir SG; Yang M; Sun X; Mu H Eur J Pharm Biopharm; 2019 Sep; 142():315-321. PubMed ID: 31299277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]